Antifibrinolytic therapy in the acute period following aneurysmal subarachnoid hemorrhage
- 1 August 1984
- journal article
- Published by Journal of Neurosurgery Publishing Group (JNSPG) in Journal of Neurosurgery
- Vol. 61 (2), 225-230
- https://doi.org/10.3171/jns.1984.61.2.0225
Abstract
Antifibrinolytic therapy remains a controversial issue in the management of subarachnoid hemorrhage (SAH). The relationship of antifibrinolytic therapy with mortality, rebleeding, ischemia, hydrocephalus, and clotting abnormalities was studied in 672 patients in the International Cooperative Study on the Timing of Aneurysm Surgery. The patients with antifibrinolytic therapy had a significantly lower rebleeding rate, but higher rates of ischemic deficits and hydrocephalus. The net result was no difference in mortality in the 1st month following the initial SAH. Further clinical trials are needed to determine the overall effects of antifibrinolytic therapy.Keywords
This publication has 9 references indexed in Scilit:
- Preoperative prognostic factors for rebleeding and survival in aneurysm patients receiving antifibrinolytic therapyNeurosurgery, 1981
- Determination of tranexamic acid (AMCA) and fibrin/fibrinogen degradation products in cerebrospinal fluid after aneurysmal subarachnoid haemorrhageActa Neurochirurgica, 1981
- Antifibrinolytic therapy in subarachnoid hemorrhage caused by ruptured intracranial aneurysmNeurology, 1981
- Antifibrinolysis with Tranexamic Acid in Aneurysmal Subarachnoid HemorrhageNeurosurgery, 1981
- Antifibrinolytic Therapy in Patients With Aneurysmal Subarachnoid HemorrhageArchives of Neurology, 1981
- Do antifibrinolytic agents prevent rebleeding after rupture of a cerebral aneurysm? A reviewClinical Neurology and Neurosurgery, 1980
- Subarachnoid HemorrhagePublished by Springer Nature ,1980
- ECHO-ENCEPHALOGRAPHIC STUDY of VENTRICULAR DILATATION AFTER SUBARACHNOID HEMORRHAGE, WITH SPECIAL REFERENCE to the EFFECT of ANTIFIBRINOLYTIC TREATMENTActa Neurologica Scandinavica, 1976